mesenchymal stem cells
Trials 291 · started per year
Also used as a comparator or background therapy in 22 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT06392711 Comparator | Oct 2024 → Nov 2028 expected | Sjogren syndrome, graft versus host disease | University of Wisconsin, Madison | Recruiting | No outcome recorded |
| Phase 1 | NCT00908856 Comparator | Jan 2016 → Dec 2017 | stroke disorder | University of California, Irvine | Withdrawn | No outcome recorded |
| Phase 1 | NCT01874015 Comparator | Feb 2013 → Dec 2017 | Crohn disease | Royan Institute | Unknown | No outcome recorded |
| Phase 1 | NCT01061099 Comparator | Feb 2010 → Mar 2013 | osteogenesis imperfecta type 2, osteogenesis imperfecta type 3 | Nationwide Children's Hospital | Completed | No outcome recorded |
| Phase 1/29 trials | ||||||
| Phase 1/2 | NCT04341610 Comparator | Apr 2020 → Jan 2021 | respiratory system disorder | Rigshospitalet, Denmark | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT05283317 Comparator | Mar 2018 → Aug 2019 | infectious disease with sepsis | TC Erciyes University | Completed | No outcome recorded |
| Phase 1/2 | NCT03326505 Comparator | Sep 2017 → Jan 2020 | multiple sclerosis | University of Jordan | Completed | No outcome recorded |
| Phase 1/2 | NCT01922908 Comparator | Dec 2016 → Dec 2018 | ischemic stroke | Sean Savitz | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT01573923 Comparator | Jul 2014 → Jul 2015 | cirrhosis of liver | Alliancells Bioscience Corporation Limited | Unknown | No outcome recorded |
| Phase 1/2 | NCT01849159 Comparator | Mar 2014 → Dec 2016 | pulmonary emphysema | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT01730547 Comparator | Feb 2013 → May 2019 | multiple sclerosis | Karolinska Institutet | Completed | No outcome recorded |
| Phase 1/2 | NCT01824121 Comparator | Dec 2012 → Dec 2014 | progressive supranuclear palsy | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Unknown | No outcome recorded |
| Phase 1/2 | NCT00225095 Comparator | Sep 2005 → Apr 2008 | — | Mesoblast, Ltd. | Completed | No outcome recorded |
| Phase 25 trials | ||||||
| Phase 2 | NCT06727721 Comparator | Nov 2023 → Dec 2028 expected | type 2 diabetes mellitus | Lu jin ，MD | Recruiting | No outcome recorded |
| Phase 2 | NCT05705024 Comparator | Sep 2023 → Sep 2026 expected | corneal ulcer | University of Illinois at Chicago | Recruiting | No outcome recorded |
| Phase 2 | NCT04416139 Comparator | May 2020 → Apr 2021 | COVID-19 | National Institute of Medical Sciences and Nutrition Salvador Zubiran | Unknown | No outcome recorded |
| Phase 2 | NCT02057211 Comparator | Apr 2014 → Nov 2017 | type 1 diabetes mellitus | Uppsala University Hospital | Terminated | No outcome recorded |
| Phase 2 | NCT02057965 Comparator | Mar 2014 → Jan 2020 | transplant rejection | Leiden University Medical Center | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01873625 Comparator | Oct 2009 → Mar 2011 | rheumatoid arthritis | Royan Institute | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02913261 Comparator | Mar 2017 → Jun 2019 | acute graft versus host disease | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT02291770 Comparator | Oct 2014 → Nov 2015 | chronic graft versus host disease | Guangdong Provincial People's Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01068951 Comparator | Jun 2010 → Sep 2013 | type 1 diabetes mellitus | Uppsala University Hospital | Completed | No outcome recorded |
Evidence & citations 65 cited values
Every value below carries the sentence it was read from. 346 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mesenchymal Stem Cells | “This is a pilot, explorative, study to test the feasibility and safety of systemic infusion of donor ex-vivo expanded Mesenchymal Stem Cells to repair the kidney and improve...” NCT01275612 ↗157“A multicenter phase I/II Clinical trial,randomized, controlled with placebo, triple blind to evaluate the safety of the intravenous administration of 3 doses of autologous...” NCT02290886 ↗ “Mesenchymal stem cells (MSCs) are known to exhibit immunomodulatory, anti-inflammatory, and pro-angiogenic properties, and therefore have the potential to improve the outcome...” NCT04247945 ↗ “Participants will be treated with mesenchymal stem cells (MSCs) eye drops, 5×10\^5 /50μl in each eye, twice a day for two weeks and they will be followed up for three months...” NCT05784519 ↗ “The purpose of this study is to assess the safety and efficacy of injectable collagen scaffold combined with Mesenchymal stem cells (MSCs) transplantation in patients with brain injury.” NCT02767817 ↗ “Mesenchymal stem cells originating from allogenic umbilical cord produced under GMP conditions will be administered in 3 times, with doses indicated below, intravenously within 1 week.” NCT04392778 ↗ “Mesenchymal stem cells (MSCs) play an important role in embryonic development and tissue regeneration in adult life owing to their high competency and self-renewal features.” PMID 25986622 ↗ 2015 “These treatments, utilizing mesenchymal stem cells (MSCs), aim to restore ocular surface health in conditions like DED by reducing inflammation and enhancing tissue repair.” NCT07191847 ↗ “Mesenchymal stem cells: intravenous infusion, 2×10⁶ cells/kg body weight/week (once weekly), with 1 to 4 administrations based on different dosage groups.” NCT07212335 ↗ “Transdermal injection of the filler agent composed of mesenchymal stem cells derived from autologous adipose tissue associated with hyaluronic acid.” NCT02034786 ↗ “Mesenchymal stem cells (MSC) are a form of multipotent adult stem cells that can be isolated from bone marrow (BM), adipose tissue, and cord blood.” NCT02083731 ↗ “Mesenchymal stem cells (MSCs) have shown immunomodulatory and regenerative effects in preclinical models and early clinical studies.” PMID 42081777 ↗ May 2026 “This study was designed to provide confirmation of safety of mesenchymal stem cells (MSCs) therapy in chronic kidney disease (CKD).” NCT02195323 ↗ “Mesenchymal stem cells (MSCs) exhibit immunomodulatory, tissue-protective, and repair-promoting properties in vitro and in animals.” PMID 28381130 ↗ Apr 2017 “Intramuscular delivery of autologous bone marrow-derived mesenchymal stem cells to patients with no option critical limb ischemia.” NCT03455335 ↗ “Autologous transplantation of bone marrow mesenchymal stem cells (approximately 2.5 x 106 cells/kg body weight) intravenously” NCT01157403 ↗ “Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.” NCT01929434 ↗ “intrathecal administration of autologous mesenchymal stem cells in participants with subacute spinal cord injury” NCT05671796 ↗ “Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful immunomodulatory function.” NCT04467047 ↗ “Allogeneic bone marrow derived mesenchymal stem cells given in one dose 3-10 days after stroke symptom onset” NCT01922908 ↗ “A Pilot Safety Study of the Administration of Mesenchymal Stem Cells (MSC) in the Treatment of Burn Wounds” NCT02104713 ↗ “Two percutaneous injections of mesenchymal stem cells, with a 3-month interval between the injections.” NCT02574585 ↗ “First passage umbilical cord-derived mesenchymal stem cells were used in the production of spheroids.” NCT05712148 ↗ “mesenchymal stem cells will be isolated from umbilical cord with informed consent from the mothers” NCT04219657 ↗ “increased number of circulating mesenchymal stem cells will provide immune modulatory properties” NCT02057211 ↗ “Multiple intra muscular injection of mesenchymal stem cells derived from human umbilical cord.” NCT01219452 ↗ “Mesenchymal stem cells (MSC) have been demonstrated to decrease immune responses of the host” NCT01213186 ↗ “Expanded, autologous mesenchymal stem cells in combination with biphasic calcium phosphate” NCT04297813 ↗ “10⁶ mesenchymal stromal cells/mesenchymal stem cells (MSCs) derived from dental pulp” NCT07305623 ↗ “timely initiation of mesenchymal stem cells(MSC) will positively influence survival” NCT03552848 ↗ “Mesenchymal stem cells (MSC) have been shown to have immunosuppressive properties.” NCT00314483 ↗ “Group B received mesenchymal stem cells in addition of routine medical therapy.” NCT01873625 ↗ “purified autologous bone marrow-derived stem cells and mesenchymal stem cells” NCT03078621 ↗ “Mesenchymal stem cells (MSCs) are a form of multipotent adult stem cells” NCT02240992 ↗ “Mesenchymal stem cells (MSCs) will be isolated through plastic adherence” NCT02334878 ↗ “Mesenchymal Stem Cells (MSCs) will be isolated and cultivated in vitro.” NCT01824121 ↗ “Intrathecal injection of mesenchymal stem cells in patients with ALS” NCT01771640 ↗ “autologous Mesenchymal Stem Cells (MSCs) characterized as above” NCT07546942 ↗ “called mesenchymal stem cells (MSCs) into your salivary glands” NCT05820711 ↗ “mesenchymal stem cells (MSCs) derived from human bone marrow” NCT02809781 ↗ “Autologous Bone Marrow Derived Mesenchymal Stem Cells (MSC)” NCT03692221 ↗ “adipose tissue derived-mesenchymal stem cells (MSCs)” NCT04611256 ↗ “bone marrow derived mesenchymal stem cells (MSCs)” NCT01874015 ↗ “augmentation of mesenchymal stem cells (MSCs)” NCT02484950 ↗ “Mesenchymal stem cells are pluripotent cells” NCT01207661 ↗ “mesenchymal stem cells therapy” NCT03683953 ↗ “mesenchymal stem cells (MSCs)” NCT02352077 ↗ |
| Known as | ADMSCs | “Allogenic adipose derived MSCs (ADMSCs) which were obtained from a healthy donor were applied to all patients in the study group.” NCT05283317 ↗ |
| Known as | ALLO-ASC-DFU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03754465 ↗ |
| Known as | allo-hMSCs | “This study presents secondary outcome findings from a randomized clinical trial in Parkinson's disease (PD), evaluating the impact of allogeneic human bone marrow-derived MSCs...” PMID 40993774 ↗ Sep 2025 |
| Known as | Allo-MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02509156 ↗ |
| Known as | alloBM-MSCs | “injection of a single dose of allogeneic bone marrow-MSCs (alloBM-MSCs) in patients with severe SSc (NCT02213705)” PMID 36928395 ↗ Apr 2023 |
| Known as | allogeneic human bone marrow-derived MSCs | “This study presents secondary outcome findings from a randomized clinical trial in Parkinson's disease (PD), evaluating the impact of allogeneic human bone marrow-derived MSCs...” PMID 40993774 ↗ Sep 2025 |
| Known as | Allogeneic Mesenchymal Stem Cells | “The aim of the study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with end-stage ischemic...” NCT01759212 ↗7“Allogeneic mesenchymal stem cells” NCT01770613 ↗ |
| Known as | AlloJoin | “A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells (AlloJoin®) Therapy for Knee Osteoarthritis.” NCT06570291 ↗ |
| Known as | AlloMSC | “Allogeneic Mesenchymal Stem Cells (AlloMSC)” NCT00962923 ↗1“Allogeneic Mesenchymal Stem Cells (AlloMSC)” NCT00953485 ↗ |
| Known as | aMBMC | “human allogeneic mesenchymal bone marrow cells (aMBMC)” NCT01770613 ↗ |
| Known as | ASCs | “using expanded autologous adipose-derived stem cells (ASCs) in cellular therapy for the treatment of PAD patients who developed chronic artery ulcers.” PMID 40202953 ↗ Apr 2025 |
| Known as | Autologous MSC from bone marrow | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02462330 ↗ |
| Known as | BM-MSC | “Ten patients will be enrolled and receive allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSC).” NCT02215811 ↗1“A single dose of autologous BM-MSC will be injected intravenously.” NCT02035514 ↗ |
| Known as | BM-MSCs | “We hypothesize that bone marrow mesenchymal stromal cells (BMMSCs) are renotropic and may improve kidney function via anti-apoptotic, anti-fibrotic, and anti-inflammatory effects.” PMID 28535817 ↗ May 20174“intravenous (IV) and intrathecal (IT) injections of bone marrow derived mesenchymal stromal cells (BM-MSCs) in patients with ALS.” PMID 30124008 ↗ Aug 2018 “Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are a viable cell-based therapy for xerostomia.” PMID 35183442 ↗ Feb 2022 “Autologous Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)” NCT02195323 ↗ “following intravenous injection of autologous bone marrow-derived MSCs (BM-MSCs).” PMID 37496411 ↗ Apr 2023 |
| Known as | Bone Marrow Derived Allogeneic Mesenchymal Stem Cells | “High dose of Bone Marrow Derived Allogeneic Mesenchymal Stem Cells will be administered through the hepatic artery” NCT01591200 ↗ |
| Known as | Bone Marrow Mesenchymal Stem Cells | “A Open Labeled and Self Controlled, Safety/Efficacy Assessed Pilot Study on Transplantation Therapy Using Bone Marrow Mesenchymal Stem Cells for Insulin Resistance of Type 2...” NCT01142050 ↗ |
| Known as | bone marrow mesenchymal stromal cells | “We hypothesize that bone marrow mesenchymal stromal cells (BMMSCs) are renotropic and may improve kidney function via anti-apoptotic, anti-fibrotic, and anti-inflammatory effects.” PMID 28535817 ↗ May 2017 |
| Known as | bone-marrow-derived-MSCs | “receive IV 1-2×10(6) bone-marrow-derived-MSCs/Kg or placebo” PMID 25436769 ↗ Dec 2014 |
| Known as | cellgram-spine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01676441 ↗ |
| Known as | CELLISTEM-OA | “Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis” NCT03810521 ↗ |
| Known as | CELULAS TRONCO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06326203 ↗ |
| Known as | Chondrogen | “Chondrogen is a preparation of adult mesenchymal stem cells (MSCs) in a solution containing hyaluronic acid.” NCT00225095 ↗ |
| Known as | CSM | “Implantation of autologous mesenchymal stem cells (CSM) expanded "in vitro" and administered directly into the lung suture line” NCT02045745 ↗ |
| Known as | hMSCs | “A single dose, one time infusion (in the vein) of one of the following doses of human mesenchymal stem cells (hMSCs): 1 x 10\^6, 3 x 10\^6 or 5 x 10\^6 human mesenchymal stem...” NCT02866721 ↗ |
| Known as | hUC-MSCs | “Human umbilical cord mesenchymal stem cells (hUC-MSCs) support revascularization” PMID 31997819 ↗ Aug 2020 |
| Known as | Human Allogenic Umbilical Cord Mesenchymal Stromal Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07058025 ↗ |
| Known as | Human Umbilical Cord Mesenchymal Stem Cells | “Human umbilical cord mesenchymal stem cells (UC-MSCs), as the "youngest" adult stem cells, have powerful anti-inflammatory functions, stronger differentiation potential, and...” NCT04562025 ↗7“We performed a phase 2 trial to assess the efficacy and safety of human umbilical cord-mesenchymal stem cells (UC-MSCs) to treat severe COVID-19 patients with lung damage.” PMID 33568628 ↗ Feb 2021 “The present clinical trial is to explore the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) therapy for novel coronavirus pneumonia patients.” NCT04293692 ↗ “Clinical Study of Moderate to Severe Persistent Allergic Rhinitis Therapy by Human Umbilical Cord Mesenchymal Stem Cells” NCT05151133 ↗ “Human Umbilical Cord-Mesenchymal Stem Cells (uc-MSCs) were derived from umbilical cord Wharton jelly” NCT06485648 ↗ “Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) therapy” NCT04273646 ↗ “Human Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs)” NCT05121870 ↗ “human umbilical cord mesenchymal stem cells (UC-MSCs)” NCT01218464 ↗ |
| Known as | human umbilical cord MSC | “human umbilical cord MSC (UC-MSCs) treatment for patients with LF.” NCT01218464 ↗ |
| Known as | Human Umbilical Cord-derived Mesenchymal Stem Cells | “Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis” NCT05121870 ↗ |
| Known as | human umbilical cord-derived MSCs | “Compared with MSCs from other sources, human umbilical cord-derived MSCs (UC-MSCs) have been widely applied to various diseases due to their convenient collection, no ethical...” NCT04293692 ↗ |
| Known as | IT-MSC | “This is a single-institution dose escalation study to determine the maximum tolerated dose (MTD) of intrathecally administered allogeneic, 3rd party mesenchymal stem cells...” NCT02410239 ↗ |
| Known as | IV-MSC | “Mesenchymal stem cells (IV-MSC)” NCT06030648 ↗ |
| Known as | marrow stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00908856 ↗ |
| Known as | Mesenchymal stem cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04492501 ↗ |
| Known as | mesenchymal stromal cells | “The BAT in this study was identified by the investigator prior to patient randomization among the following treatments currently used in this setting: anti-thymocyte globulin...” NCT02913261 ↗46“we expect that ex-vivo expanded donor bone-marrow derived mesenchymal stromal cells (MSC) infusion would allow to accelerate tubular regeneration and thus renal function...” NCT01275612 ↗ “Patients with newly diagnosed untreated acute graft versus host disease grades 2-4 will receive methylprednisolone 2.5mg/kg intravenously and randomised to receive or not...” NCT01589549 ↗ “Objective: To determine whether patients with emphysema develop anti-inflammatory and tissue repair responses by treatment with allogeneic bone marrow-derived mesenchymal...” NCT04918706 ↗ “intrathecal and intravenous administration of autologous mesenchymal stem cells (MSCs) (also called mesenchymal stromal cells) in patients with multiple sclerosis (MS) and...” PMID 20937945 ↗ Oct 2010 “Mesenchymal stromal cells (MSCs) have recently emerged as an interesting therapeutic approach for patients with progressive systemic sclerosis (SSc), a rare and...” PMID 36928395 ↗ Apr 2023 “autologous bone marrow-derived mesenchymal stromal cells (MSCs) as part of a phase 1 study focused on the safety and feasibility of this cell therapy.” PMID 29963053 ↗ Jun 2018 “A Phase I Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Xerostomia After Radiation Therapy for Head and Neck Cancer” NCT05820711 ↗ “intravenous (IV) and intrathecal (IT) injections of bone marrow derived mesenchymal stromal cells (BM-MSCs) in patients with ALS.” PMID 30124008 ↗ Aug 2018 “Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)” NCT02195323 ↗ “Mesenchymal stromal cells (MSC) have been shown to improve neurological function following spinal cord injury.” PMID 39328312 ↗ Sep 2024 “Co-transplantation of Mesenchymal Stromal Cells in Allogeneic Hematopoietic Stem Cell Transplantation” NCT04247945 ↗ “10⁶ mesenchymal stromal cells/mesenchymal stem cells (MSCs) derived from dental pulp” NCT07305623 ↗ “Mesenchymal stromal cells (MSCs) are an ideal candidate” NCT06163833 ↗ “Mesenchymal Stromal Cells (MSCs)” NCT02351011 ↗ |
| Known as | Mesenchymal Stromal Cells (MSCs) | “Mesenchymal Stromal Cells (MSCs)” NCT02351011 ↗ |
| Known as | mesenchymal stromal/stem cells | “Mesenchymal stromal/stem cells (MSCs) are cells that can be derived from umbilical cords, bone marrow, adipose tissue, and dental pulp, among other sites.” NCT03171194 ↗ |
| Known as | MKH | “Mesenchymal stem cells (MKH) not only inhibit the abnormal activation of T lymphocytes and macrophages, but also encourage them to differentiate into regulatory T cell subsets...” NCT04392778 ↗ |
| Known as | MSC | “we expect that ex-vivo expanded donor bone-marrow derived mesenchymal stromal cells (MSC) infusion would allow to accelerate tubular regeneration and thus renal function...” NCT01275612 ↗32“In mesenchymal stem cells (MSC) group, UC-MSCs were injected intravenously at a dose of 1 × 106/kg per week starting on the 14th day after administration of rabbit...” PMID 33639900 ↗ Feb 2021 “Objective: To determine whether patients with emphysema develop anti-inflammatory and tissue repair responses by treatment with allogeneic bone marrow-derived mesenchymal...” NCT04918706 ↗ “The principal aim of this trial is to assess the safety of non-mutated HLA-identical Mesenchymal stem cell (MSC) transplantation for OI pediatric patients irrespective of...” NCT02172885 ↗ “Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of allogeneic bone marrow-derived mesenchymal stromal cells (MSC) over a 6- to...” PMID 32573983 ↗ Jun 2020 “Mesenchymal stromal cells (MSC) have emerged as a promising therapy to minimize the immunosuppressive regimen or induce tolerance in solid organ transplantation.” PMID 33370477 ↗ Feb 2021 “Mesenchymal stem cells (MSC) are a form of multipotent adult stem cells that can be isolated from bone marrow (BM), adipose tissue, and cord blood.” NCT02083731 ↗ “Third party donor Mesenchymal Stem Cells (MSC) will be administered via intrathecal administration at the assigned dose on days 0, 7 and 14.” NCT02410239 ↗ “Mesenchymal stem cells (MSC) have been shown to prevent inflammation and neurodegeneration in animal models of MS” PMID 31072380 ↗ May 2019 “Mesenchymal stem cell (MSC) infusion could represent a novel tolerogenic cell therapy in kidney transplantation.” NCT00752479 ↗ “Mesenchymal stromal cells (MSC) have been shown to improve neurological function following spinal cord injury.” PMID 39328312 ↗ Sep 2024 “A Pilot Safety Study of the Administration of Mesenchymal Stem Cells (MSC) in the Treatment of Burn Wounds” NCT02104713 ↗ “Augmentation of atrophied alveolar ridge with mesenchymal stem cells( MSC) and bis calcium phosphate(BCP)” NCT02751125 ↗ “Mesenchymal stromal cells (MSC) intravenous infusion at least two fixed doses of mesenchymal stem cells” NCT01764100 ↗ “Mesenchymal stem cells (MSC) have been demonstrated to decrease immune responses of the host” NCT01213186 ↗ “The plasticity of Mesenchymal Stem Cells (MSC) regulates inflammation and immunity.” NCT04416139 ↗ “Mesenchymal stem cells (MSC) have been shown to have immunosuppressive properties.” NCT00314483 ↗ “Mesenchymal stem (stromal) cells (MSC) have potent immunomodulatory properties” NCT02957552 ↗ “Mesenchymal stem cells (MSC) induce immune-modulatory and neurotrophic effects” NCT02166021 ↗ “infused intravenously with Mesenchymal Stem Cells (MSC)” NCT04047810 ↗ “mesenchymal stem cells (MSC) can be expanded in vitro” NCT01207661 ↗ “Mesenchymal Stromal Cells (MSC) Dose Level 0” NCT06392711 ↗ “Mesenchymal stromal cells (MSC) for infusion” NCT01090817 ↗ “Biological: Mesenchymal Stem Cells (MSC)” NCT02501811 ↗ “Biological: Mesenchymal Stem Cells (MSC)” NCT01540292 ↗ “allogeneic mesenchymal stem cells (MSC)” NCT02104440 ↗ “autologous Mesenchymal Stem Cells (MSC)” NCT01854957 ↗ “Drug: Mesenchymal Stromal Cells (MSC)” NCT06146062 ↗ “Mesenchymal stem cells (MSC)” NCT04821479 ↗ |
| Known as | MSC (hPPL) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00827398 ↗ |
| Known as | MSC(M) | “interferon gamma (IFNγ)-stimulated autologous bone marrow-derived MSCs, or MSC(M), for the treatment of radiation-induced xerostomia (RIX).” PMID 37589639 ↗ Aug 2023 |
| Known as | MSCs | “Mesenchymal stem cells (MKH) not only inhibit the abnormal activation of T lymphocytes and macrophages, but also encourage them to differentiate into regulatory T cell subsets...” NCT04392778 ↗67“This Phase IIB, multicenter, double-blind, randomized, and uncontrolled clinical trial aims to assess the efficacy and safety of subconjunctival injection of Mesenchymal Stem...” NCT06905834 ↗ “Purpose: This prospective clinical case series aimed to evaluate the effect of suprachoroidal implantation of mesenchymal stem cells (MSCs) in the form of spheroids as a stem...” NCT05712148 ↗ “Mesenchymal stem cells (MSCs) are known to exhibit immunomodulatory, anti-inflammatory, and pro-angiogenic properties, and therefore have the potential to improve the outcome...” NCT04247945 ↗ “Among several treatment modalities, mesenchymal stem cells (MSCs) transplantation is promising for autoimmune disorders due to immunomodulation, regeneration, and migration to...” PMID 35725652 ↗ Jun 2022 “intrathecal and intravenous administration of autologous mesenchymal stem cells (MSCs) (also called mesenchymal stromal cells) in patients with multiple sclerosis (MS) and...” PMID 20937945 ↗ Oct 2010 “Mesenchymal stromal cells (MSCs) have recently emerged as an interesting therapeutic approach for patients with progressive systemic sclerosis (SSc), a rare and...” PMID 36928395 ↗ Apr 2023 “A single patient safety study for harvesting, expanding ex vivo and injecting autologous mesenchymal stem cells (MSC's) into the subarachnoid space of a patient with...” NCT01142856 ↗ “Mesenchymal stem cells (MSCs) are particularly attractive therapeutic agents because of their ability to self-renew, differentiate into multi lineage cell types, and locally...” NCT02387749 ↗ “This study was designed to provide confirmation of safety of mesenchymal stem cells (MSCs) therapy in chronic renal failure due to autosomal dominant polycystic kidney disease (ADPKD).” NCT02166489 ↗ “The therapeutic and immunomodulatory potential of mesenchymal stem cells (MSCs) in rheumatoid arthritis (RA) has attracted considerable scientific attention in recent decades.” PMID 37496411 ↗ Apr 2023 “Mesenchymal stem cells (MSCs) play an important role in embryonic development and tissue regeneration in adult life owing to their high competency and self-renewal features.” PMID 25986622 ↗ 2015 “The therapeutic plasticity of mesenchymal stem cells (MSCs) may be an attractive therapy to this complex disease, turning MSCs strong candidates for cellular therapy in ALS.” NCT02987413 ↗ “These treatments, utilizing mesenchymal stem cells (MSCs), aim to restore ocular surface health in conditions like DED by reducing inflammation and enhancing tissue repair.” NCT07191847 ↗ “Cell therapy with mesenchymal stem cells (MSCs), osteoprogenitors capable of secreting type I collagen, has been tested to treat pediatric OI with encouraging outcomes.” PMID 35223854 ↗ Feb 2022 “G. Zhen et al. have shown that the transplantation of mesenchymal stem cells (MSCs) to rats with papain-induced emphysema leads to their migration into the lungs” NCT01849159 ↗ “Mesenchymal stromal/stem cells (MSCs) are cells that can be derived from umbilical cords, bone marrow, adipose tissue, and dental pulp, among other sites.” NCT03171194 ↗ “autologous bone marrow-derived mesenchymal stromal cells (MSCs) as part of a phase 1 study focused on the safety and feasibility of this cell therapy.” PMID 29963053 ↗ Jun 2018 “Mesenchymal stem cells (MSCs) are a form of multipotent adult stem cells that can be isolated from bone marrow (BM), adipose tissue, and cord blood.” NCT04692376 ↗ “intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells (MSCs) in patients with rheumatoid arthritis” PMID 29428486 ↗ Feb 2018 “Recent studies have demonstrated that mesenchymal stem cells (MSCs) modulate the immune response and reduce lung injury in animal models.” PMID 24708472 ↗ Apr 2014 “A specific form of stem cells, called adult mesenchymal stem cells (MSCs), has shown remarkable ability to modulate the immune response.” NCT02403947 ↗ “The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow.” NCT05705024 ↗ “Mesenchymal stem cells (MSCs) exhibit immunomodulatory, tissue-protective, and repair-promoting properties in vitro and in animals.” PMID 28381130 ↗ Apr 2017 “Mesenchymal stromal cells (MSCs), identified within the bone marrow stroma, are a type of non-hematopoietic multipotent stem cells.” NCT06171906 ↗ “This study was designed to provide confirmation of safety of mesenchymal stem cells (MSCs) therapy in chronic kidney disease (CKD).” NCT02195323 ↗ “allogeneic human umbilical cord derived-mesenchymal stem cells (MSCs) is administered via intravenous infusion on day 0 and day 7” NCT04194671 ↗ “Mesenchymal stem cells (MSCs) can differentiate into specific cell lineages and have the capacity of homing in sites of injury.” PMID 24876849 ↗ May 2014 “The trial is a phase 1b, open label, uncontrolled, non-randomized dose-escalation study of autologous bone marrow-derived MSCs.” NCT03455335 ↗ “Mesenchymal stem cells [MSCs] have been used for the treatment of perianal Crohn's fistulising disease by direction injection.” PMID 36322714 ↗ Apr 2023 “mesenchymal stromal cells (MSCs) are an interesting candidate because of their immunosuppressive and regenerative properties.” PMID 23349326 ↗ Jan 2013 “Participants will receive a single IV infusion of Mesenchymal Stem Cells (MSCs) 1 x 10\^6 cells/kg in Plasma-Lyte A solution.” NCT02633163 ↗ “Mesenchymal stem cells (MSCs) have been shown to possess a comprehensive powerful immunomodulatory function.” NCT04467047 ↗ “Mesenchymal stromal cells (MSCs) may reduce inflammation and promote tissue repair in pulmonary emphysema.” PMID 26819296 ↗ Jan 2016 “clinical safety and efficacy of mesenchymal stem cells (MSCs) in sepsis and septic shock patients” PMID 35784641 ↗ Jun 2022 “Autologous MSCs were expanded in five cases, in one case MSCs expansion was insufficient.” PMID 37904229 ↗ Oct 2023 “mesenchymal stem cells (MSCs) in multiple sclerosis suggested some beneficial effect” PMID 25436769 ↗ Dec 2014 “10⁶ mesenchymal stromal cells/mesenchymal stem cells (MSCs) derived from dental pulp” NCT07305623 ↗ “allogeneic, umbilical cord-derived (UC) mesenchymal stromal cells (MSCs)” NCT04865107 ↗ “Mesenchymal stem cells (MSCs) will be isolated through plastic adherence” NCT02334878 ↗ “Mesenchymal Stem Cells (MSCs) will be isolated and cultivated in vitro.” NCT01824121 ↗ “Patients in both treatment arms receive intrathecal autologous MSCs” NCT04749667 ↗ “autologous bone marrow-derived Mesenchymal Stromal Cells (MSCs)” NCT04489732 ↗ “called mesenchymal stem cells (MSCs) into your salivary glands” NCT05820711 ↗ “receive treatment with expanded mesenchymal stem cells (MSCs).” NCT06326203 ↗ “adipose tissue derived-mesenchymal stem cells (MSCs)” NCT04611256 ↗ “Autologous Mesenchymal Stem Cells Treatment (MSCs)” NCT04326985 ↗ “human umbilical cord mesenchymal stem cells (MSCs)” NCT06911281 ↗ “bone marrow derived mesenchymal stem cells (MSCs)” NCT01874015 ↗ “administration of mesenchymal stem cells (MSCs)” NCT06416709 ↗ “augmentation of mesenchymal stem cells (MSCs)” NCT02484950 ↗ “Allogeneic mesenchymal stromal cells (MSCs)” NCT05333029 ↗ “Autologous mesenchymal stromal cells (MSCs)” NCT02359929 ↗ “BM-derived MSCs were isolated and cultured” PMID 26058927 ↗ Jun 2015 “Mesenchymal Stromal Cells (MSCs)” NCT02351011 ↗ “Mesenchymal Stem Cells (MSCs)” NCT04061746 ↗ “Mesenchymal Stem Cells (MSCs)” NCT02804945 ↗ “Mesenchymal Stem Cells (MSCs)” NCT06438809 ↗ “Mesenchymal Stem Cells (MSCs)” NCT06149832 ↗ “Mesenchymal stem cells (MSCs)” NCT05925036 ↗ “mesenchymal stem cells (MSCs)” NCT02352077 ↗ “Mesenchymal Stem Cells(MSCs)” NCT02706132 ↗ |
| Known as | multipotent mesenchymal stromal cells | “Patient will receive bone marrow derived allogeneic multipotent mesenchymal stromal cells infusion 48 hours after last administration of cytotoxic agent .” NCT02145923 ↗ |
| Known as | Stem Cell Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04341610 ↗ |
| Known as | Stem Cells,Mesenchymal | “Biological: Stem Cells,Mesenchymal” NCT02334878 ↗ |
| Known as | Stempeucel - CLI | “Intramuscular Administration of Stempeucel - CLI™ (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells)” NCT01484574 ↗ |
| Known as | TC-MSC | “TC-MSC: a cell product containing mesenchymal stromal cells.” NCT02323789 ↗ |
| Known as | UC-MSC | “A safety and feasibility study was completed on the use of umbilical cord MSC (UCMSC) as a treatment for MS.” PMID 29523171 ↗ Mar 20183“repeated delivery of Umbilical Cord Mesenchymal Stromal Cells (UC-MSC) intravenously.” NCT04400032 ↗ “umbilical cord-derived mesenchymal stem cells (UC-MSC)” NCT05939817 ↗ “umbilical cord-derived mesenchymal stem cells (UC-MSC)” NCT05887804 ↗ |
| Known as | UC-MSCs | “In mesenchymal stem cells (MSC) group, UC-MSCs were injected intravenously at a dose of 1 × 106/kg per week starting on the 14th day after administration of rabbit...” PMID 33639900 ↗ Feb 202147“Umbilical cord-derived mesenchymal stem cells (UCMSCs) have been shown to repair damaged liver, kidney, heart, pancreas, skin, cartilage, and cornea in animal models and...” NCT04437823 ↗ “This intervention consists of a single intra-renal injection of allogeneic umbilical cord-derived mesenchymal stem cells (UC-MSCs) administered under imaging guidance.” NCT07396155 ↗ “allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard frailty treatment” NCT04919135 ↗ “Human Umbilical Cord-Mesenchymal Stem Cells (uc-MSCs) were derived from umbilical cord Wharton jelly” NCT06485648 ↗ “This is a phase I, open label, single arm trial using UC-MSCs to treat patients with liver cirrhosis” NCT05331872 ↗ “allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) as a supplementary intervention” NCT04433104 ↗ “collagen scaffold/umbilical cord mesenchymal stem cells (CS/UC-MSCs) on this refractory disease.” PMID 34294152 ↗ Jul 2021 “In this study, UC-MSCs were used to treat patients with hormone-controlled Crohn's disease.” NCT02445547 ↗ “human umbilical cord mesenchymal stem cells (UC-MSCs) via peripheral vein transfusion” NCT01218464 ↗ “Umbilical cord derived mesenchymal stem cells (UC-MSCs) derived from mesoderm” NCT03550183 ↗ “umbilical cord derived mesenchymal stem cells (UCMSCs) suspension” NCT03608592 ↗ “umbilical cord derived mesenchymal stem cells (UC-MSCs)” NCT05672420 ↗ “Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)” NCT01547091 ↗ “Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)” NCT07011199 ↗ “umbilical-cord derived mesenchymal stem cells (UC-MSCs)” NCT04457609 ↗ “human umbilical cord mesenchymal stem cells (UC-MSCs)” NCT02235844 ↗ “Umbilical-cord mesenchymal stromal cells (UC-MSCs)” NCT03166865 ↗ “umbilical cord mesenchymal stem cells (UC-MSCs)” NCT05682586 ↗ “umbilical cord mesenchymal stem cells (UCMSCs)” NCT02666391 ↗ |
| Known as | Umbilical Cord Derived Mesenchymal Stem Cells | “Umbilical cord-derived mesenchymal stem cells (UCMSCs) have been shown to repair damaged liver, kidney, heart, pancreas, skin, cartilage, and cornea in animal models and...” NCT04437823 ↗13“BACKGROUND: To determine the efficacy and safety of umbilical cord-derived mesenchymal stem cells (UC-MSCs) in Chinese adults with type 2 diabetes mellitus (T2DM).” PMID 35505375 ↗ May 2022 “Umbilical Cord Derived Mesenchymal Stem Cells at a dose of 100-800 million by intravenous infusion” NCT01962233 ↗ |
| Known as | Umbilical Cord Mesenchymal Stem Cell | “Umbilical Cord Mesenchymal Stem Cell (UC-MSCs)” NCT05279768 ↗ |
| Known as | Umbilical cord Mesenchymal Stem Cells | “This study aims to determine the efficacy, mechanism of action, and safety of umbilical cord mesenchymal stem cells as a therapy for ED due to type 2 diabetes in human.” NCT04972890 ↗49“Umbilical Cord Mesenchymal Stem Cells Between Gel Treatment Difficult Skin Ulcer Healing Efficacy and Safety of Random, Open, Before-and-after Study” NCT02685722 ↗ “Thus far, the use of umbilical cord mesenchymal stem cells (UC-MSCs) to treat Crohn's disease has rarely been reported.” NCT02445547 ↗ “Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease” NCT05152160 ↗ “Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Long COVID-19” NCT05719012 ↗ “Umbilical cord Mesenchymal Stem Cells (UCMSCs) in the treatment of Allergic rhinitis (AR)” NCT05151133 ↗ “the clinical use of umbilical cord mesenchymal stem cells has been approved by FDA” NCT03336996 ↗ “Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus” NCT01954147 ↗ “Transplantation of umbilical cord mesenchymal stem cells” NCT04062136 ↗ “umbilical cord mesenchymal stem cells (UCMSCs)” NCT05155657 ↗ “umbilical cord mesenchymal stem cells” NCT05689008 ↗ |
| Known as | Umbilical Cord Mesenchymal Stromal Cells | “repeated delivery of Umbilical Cord Mesenchymal Stromal Cells (UC-MSC) intravenously.” NCT04400032 ↗ |
| Known as | umbilical cord MSC | “A safety and feasibility study was completed on the use of umbilical cord MSC (UCMSC) as a treatment for MS.” PMID 29523171 ↗ Mar 2018 |
| Known as | umbilical cord MSCs | “10\^6 (1 million) /Kg/person cells of clinical grade umbilical cord MSCs will be injected after whole-lung lavage” NCT02668068 ↗ |
| Known as | Umbilical Cord Tissue Derived Mesenchymal Stem Cells (UCMSCs) | “Umbilical Cord Tissue Derived Mesenchymal Stem Cells (UCMSCs) administered intravenously in patients with acute pulmonary inflammation due to COVID-19” NCT04490486 ↗ |
| Known as | umbilical cord-derive mesenchymal stem cells | “Recent clinical trials demonstrate that bone marrow-derived stem cells (BMDSCs) as well as umbilical cord-derive mesenchymal stem cells (UC-MSCs) improve liver function in...” NCT05331872 ↗ |
| Known as | umbilical cord-derived MSCs | “umbilical cord-derived MSCs (ucMSCs) is safe and effective as a rescue treatment for severe BPD.” NCT01207869 ↗ |
| Known as | UMC119-06-05 | “This Phase I/II study is designed to evaluate the efficacy and safety of UMC119-06-05, an allogeneic umbilical cord mesenchymal stem cells, in older adults with frailty syndrome.” NCT06501066 ↗ |
| Known as | WJ-MSCs | “The purpose of this study is to explore the effect of combining physical therapy exercises (PTE) and Wharton Jelly mesenchymal stem cell (WJ-MSCs) injections on motor and...” PMID 32846775 ↗ Aug 2020 |
| Known as | WJ-UC-MSC | “repeated intravenous treatment with mesenchymal stromal cells derived from Wharton's Jelly of the umbilical cord-derived mesenchymal stromal cells ((WJ-UC-MSC) may be...” PMID 39740941 ↗ Dec 2024 |
| Action | Restore | “make its differentiation to form new blood capillary, improve and restore the local blood flow.” NCT02304588 ↗ |
| Modality | Cell therapy | “allogeneic human mesenchymal stem cells” PMID 24430407 ↗ Jan 2014 |
| Route | Other | “intra-articular injection of human mesenchymal stem cells into the knee” PMID 24430407 ↗ Jan 2014 |